ArticleCureus2024
Prevalence of Idiopathic Macular Hole in a Specialized Ophthalmological Referral Center: A Retrospective Cross-Sectional Study (2018-2022).
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vitrectomy with inner limiting membrane peeling effectively reduces ellipsoid zone defect diameter in patients with idiopathic macular holes.American journal of translational research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn idiopathic macular hole (IMH) is a foveal opening in the neurosensory retina caused by perifoveal vitreomacular traction and detachment. IMH prevalence varies considerably across populations, highlighting a need for further investigation, especially in underrepresented groups such as Hispanics.
methodsThis retrospective, descriptive, cross-sectional study analyzed IMH prevalence in a Hispanic population over four years. Electronic records of patients were reviewed at a single referral center. All patients aged 18 years and above who presented for a first-time comprehensive ophthalmology evaluation were included. IMH diagnosis was clinically made and confirmed with optical coherence tomography (OCT). Data analysis involved descriptive and inferential statistics, adhering to Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.
resultsOf 116,655 electronic records analyzed from March 2018 to July 2022, 397 subjects were identified in our analysis. The estimated prevalence of IMH was 0.34% (95% confidence interval (CI): 0.307-0.375), with a female-to-male ratio of 4:1. The mean age of the participants was 67.75 ± 9.38 years. Initial visual acuity, laterality, comorbidities, and clinical findings were assessed. No significant gender differences were documented. Subgroup analyses revealed significant age discrepancies based on comorbidities and clinical symptoms.
conclusionsOur study provides insight into the prevalence of IMHs in a Hispanic population. Its findings are similar to those published for other populations. The observed prevalence emphasizes the importance of proactive screening for IMHs in older patients, especially if they are women. Clinical markers such as the Watzke-Allen sign are helpful in the early detection of IMHs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.